Medicare Enrolled
Dr. John Isaac, M.D.
Interventional Cardiology · Houston, TX
Practice pattern: Cardiac & Remote— Practice combining cardiac and remote services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Isaac from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Isaac? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Isaac
Dr. John Isaac is an interventional cardiology in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Isaac performed 10,550 Medicare services across 6,121 unique beneficiaries.
Between the years covered by Open Payments, Dr. Isaac received a total of $1,956,906 from 65 pharmaceutical and/or device companies across 3572 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Isaac is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 2% volume in TX$ $1,956,906 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,550
Medicare services
Top 2% in TX for interventional cardiology
6,121
Unique beneficiaries
$186
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~555 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,306 | $98 | $400 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,860 | $43 | $100 |
| Echocardiogram, transthoracic | 731 | $151 | $1,300 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 710 | $20 | $125 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 709 | $28 | $145 |
| Ultrasound of both sides of head and neck blood flow | 608 | $154 | $650 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 551 | $56 | $345 |
| Electrocardiogram (EKG), 12-lead | 429 | $11 | $90 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 402 | $637 | $814 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 398 | $1,976 | $8,000 |
| Remote pacemaker/defibrillator monitoring, 90 days | 213 | $17 | $125 |
| Remote pacemaker monitoring, 90 days | 188 | $22 | $125 |
| Hospital follow-up visit, moderate complexity | 170 | $65 | $145 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 152 | $353 | $2,925 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 148 | $64 | $81 |
| New patient office visit (45-59 min) | 109 | $115 | $525 |
| Office visit, established patient, complex (40-54 min) | 76 | $139 | $565 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 64 | $213 | $900 |
| Initial hospital admission, moderate complexity | 64 | $106 | $270 |
| Telephone medical discussion with physician, 21-30 minutes | 55 | $104 | $500 |
| Hospital follow-up visit, high complexity | 54 | $98 | $190 |
| Ultrasound of leg arteries or artery grafts | 52 | $198 | $707 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 51 | $10 | $50 |
| Remote patient monitoring management, 20 min/month | 49 | $36 | $160 |
| Cardiac catheterization | 39 | $187 | $2,500 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 38 | $690 | $2,200 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 37 | $155 | $600 |
| Therapy procedure using a positive pressure ventilator | 37 | $52 | $275 |
| Insertion of heart rhythm monitor under skin | 35 | $3,600 | $15,900 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 35 | $20 | $85 |
| Measurement of brain wave activity (eeg), 61-84 hours with health care professional review and report | 28 | $202 | $690 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 25 | $20 | $145 |
| Initial hospital admission, high complexity | 24 | $143 | $400 |
| Coronary stent placement | 20 | $464 | $3,300 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 20 | $210 | $950 |
| Sleep study including heart rate, breathing, airflow, and effort | 19 | $42 | $400 |
| New patient office visit, complex (60-74 min) | 19 | $153 | $690 |
| External shock to heart to regulate heart beat | 13 | $85 | $571 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 12 | $78 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.3% high complexity
35.1% medium
53.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,956,906
Total received (2018-2024)
Avg $279,558/year across 7 years
Top 1% in TX for interventional cardiology
65
Companies
3,572
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,909,832 (97.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,052 (1.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$19,022 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$199,532
2023$139,851
2022$283,273
2021$273,072
2020$233,187
2019$435,390
2018$392,599
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Esperion Therapeutics, Inc.
$355,522
AstraZeneca Pharmaceuticals LP
$241,620
Amgen Inc.
$232,553
SANOFI-AVENTIS U.S. LLC
$184,670
Boehringer Ingelheim Pharmaceuticals, Inc.
$152,485
Janssen Pharmaceuticals, Inc
$130,445
E.R. Squibb & Sons, L.L.C.
$125,081
Regeneron Healthcare Solutions, Inc.
$104,200
Amarin Pharma Inc.
$87,339
Novartis Pharmaceuticals Corporation
$79,367
Lilly USA, LLC
$66,000
PFIZER INC.
$48,991
Kiniksa Pharmaceuticals International, plc
$48,405
Kiniksa Pharmaceuticals, Ltd.
$27,311
Impulse Dynamics (USA) Inc.
$16,033
Althera Pharmaceuticals LLC
$13,751
Boston Scientific Corporation
$13,340
Novo Nordisk Inc
$10,447
Abbott Laboratories
$8,336
BOSTON SCIENTIFIC CORPORATION
$1,651
Philips Electronics North America Corporation
$1,295
Medtronic Vascular, Inc.
$1,068
Medtronic, Inc.
$1,003
ABIOMED
$592
BIOTRONIK INC.
$505
Merck Sharp & Dohme LLC
$492
HeartFlow, Inc.
$434
ARALEZ PHARMACEUTICALS US INC.
$395
Kowa Pharmaceuticals America, Inc.
$377
Astellas Pharma US Inc
$291
Actelion Pharmaceuticals US, Inc.
$280
Watermark Medical, Inc.
$224
Regeneron Pharmaceuticals, Inc.
$196
BTG International, Inc.
$170
ARBOR PHARMACEUTICALS, INC.
$141
Lundbeck LLC
$137
Aziyo Biologics, Inc.
$124
Bayer Healthcare Pharmaceuticals Inc.
$123
Lexicon Pharmaceuticals, Inc.
$123
iRhythm Technologies, Inc.
$120
Acacia Pharma Inc
$117
Preventice Services, LLC
$116
Bard Peripheral Vascular, Inc.
$109
Gilead Sciences, Inc.
$105
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$82
Arbor Pharmaceuticals, Inc.
$78
Inspire Medical Systems, Inc.
$64
Tactile Systems Technology Inc
$62
Merck Sharp & Dohme Corporation
$57
CARDIVA MEDICAL, INC.
$52
G Medical Diagnostic Services, Inc.
$42
AltaThera Pharmaceuticals LLC
$41
Smith & Nephew, Inc.
$37
HEARTFLOW, INC.
$36
Medicure Pharma Inc.
$35
Smith+Nephew, Inc.
$32
Avinger Inc.
$32
Alnylam Pharmaceuticals Inc.
$31
Chiesi USA, Inc.
$25
CVRx, Inc.
$24
AGEPHA Pharma FZ LLC
$21
SCPHARMACEUTICALS INC.
$20
Edwards Lifesciences Corporation
$18
Ethicon US, LLC
$18
CHIESI USA, INC.
$16
Top 3 companies account for 42.4% of total payments
Associated products mentioned in payments ›
ACCENT · AIRSUPRA · ATTAIN COMMAND + SUREVALVE · AZURE XT DR MRI SURESCAN · Accent Pacemaker · Advisa · Allure Quadra RF CRT Pacemaker · Aranesp · Arcalyst · Assurity Pacemaker · Axium INS DRG IPG · Azure · BREZTRI · BRILINTA · BYFAVO · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CHANTIX · CLEVIPREX 50MG/100ML · COBALT DR MRI SURESCAN · CONFIRM RX · COROFLOW · CRESEMBA · Cardiac Monitoring Suite · Circulatory Support · Claria MRI · Cobalt · Confirm Rx · CoreValve Evolut · Corlanor · DERMABOND Portfolio · DIAMONDBACK PERIPHERAL · DISEASE STATE · DRAGONFLY OPSTAR · ECM Patch · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · Evera · FARXIGA · FFRct · FLEXITOUCH · FORTIFY ASSURA · FUROSCIX · Flexitouch Plus · General - Therapies · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Horizant · INSPIRE · Image Guided Therapy Devices _ Coronary · Impella · Inpefa · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LIFESTENT · LINQ II · LIVALO · LODOCO · LUTONIX · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MERLIN@HOME · MRI Ready Leads · MULTAQ · Merlin Connectivity and Remote · Micra · Mitra Clip system · NEXLETOL · NEXLIZET · NORTHERA · ONYX FRONTIER · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · OPTIS · OPTISURE · Optimizer · Optimizer Smart System · Ozempic · PANTHERIS · PERCEPTA QUAD CRT-P MRI SURESCAN · PICO · PICO Single Use Negative Pressure Wound Therapy · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · Percepta · Pouch · Quadra Assura CRT Defibrillator · RESONATE EL ICD VR · Repatha · Reveal LINQ · Roszet · Rybelsus · SEEQ · SELECTSECURE · SOLARA QUAD CRT-P MRI SURESCAN · SYNERGY · Sotalol Hydrochloride · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TactiCath Quartz CFA Catheter · UPTRAVI · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · XIENCE SKYPOINT · XIENCE V · XIENCE XPEDITION · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · ZIO Patch · ZIO XT Patch · ZONTIVITY · ZYPITAMAG · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for interventional cardiology in TX.
Equivalent to $18,549 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
62
Per 100K population
1.3
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Isaac is a cardiac & remote specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Isaac experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Isaac performed 2,306 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Isaac receive payments from pharmaceutical companies?
Yes. Dr. Isaac received a total of $1,956,906 from 65 companies across 3,572 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Isaac's costs compare to other interventional cardiologys in Houston?
Dr. Isaac's average Medicare payment per service is $186. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Isaac) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Houston
Browse interventional cardiologys in Houston ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Esperion Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Esperion Therapeutics, Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology